YiChang HEC ChangJiang Ph... (YIHCF)
YiChang HEC ChangJiang Pharmaceutical Statistics
Share Statistics
YiChang HEC ChangJiang Pharmaceutical has 2.57B shares outstanding. The number of shares has increased by 6.86% in one year.
| Shares Outstanding | 2.57B |
| Shares Change (YoY) | 6.86% |
| Shares Change (QoQ) | 0.76% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 1.73 and the forward PE ratio is null. YiChang HEC ChangJiang Pharmaceutical's PEG ratio is 0.
| PE Ratio | 1.73 |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/FCF Ratio | 3.19 |
| PEG Ratio | 0 |
Enterprise Valuation
YiChang HEC ChangJiang Pharmaceutical has an Enterprise Value (EV) of 4.38B.
| EV / Sales | 0.7 |
| EV / EBITDA | 1.59 |
| EV / EBIT | 2.62 |
| EV / FCF | 4.06 |
Financial Position
The company has a current ratio of 1.4, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.4 |
| Quick Ratio | 1.3 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 0.95 |
| Debt / FCF | 2.42 |
| Interest Coverage | 10.35 |
Financial Efficiency
Return on Equity is 25.11% and Return on Invested Capital is 19.14%.
| Return on Equity | 25.11% |
| Return on Assets | 15.64% |
| Return on Invested Capital | 19.14% |
| Revenue Per Employee | $1,363,054.35 |
| Profits Per Employee | $431,490.69 |
| Employee Count | 4,618 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3.2 |
Taxes
| Income Tax | 270.94M |
| Effective Tax Rate | 12.74% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.11, so YiChang HEC ChangJiang Pharmaceutical's price volatility has been higher than the market average.
| Beta | 0.11 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.55 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 100 |
| Average Volume (20 Days) | 3,097 |
Income Statement
In the last 12 months, YiChang HEC ChangJiang Pharmaceutical had revenue of 6.29B and earned 1.99B in profits. Earnings per share was 2.26.
| Revenue | 6.29B |
| Gross Profit | 4.99B |
| Operating Income | 2.35B |
| Net Income | 1.99B |
| EBITDA | 2.75B |
| EBIT | 2.35B |
| Earnings Per Share (EPS) | 2.26 |
Balance Sheet
The company has 1.67B in cash and 2.61B in debt, giving a net cash position of -934.91M.
| Cash & Cash Equivalents | 1.67B |
| Total Debt | 2.61B |
| Net Cash | -934.91M |
| Retained Earnings | 4.39B |
| Total Assets | 12.49B |
| Working Capital | 2.93B |
Cash Flow
In the last 12 months, operating cash flow was 1.67B and capital expenditures -595.08M, giving a free cash flow of 1.08B.
| Operating Cash Flow | 1.67B |
| Capital Expenditures | -595.08M |
| Free Cash Flow | 1.08B |
| FCF Per Share | 1.22 |
Margins
Gross margin is 79.21%, with operating and profit margins of 37.4% and 31.66%.
| Gross Margin | 79.21% |
| Operating Margin | 37.4% |
| Pretax Margin | 33.79% |
| Profit Margin | 31.66% |
| EBITDA Margin | 43.62% |
| EBIT Margin | 37.4% |
| FCF Margin | 17.13% |
Dividends & Yields
YIHCF pays an annual dividend of $0.11, which amounts to a dividend yield of 6.51%.
| Dividend Per Share | $0.11 |
| Dividend Yield | 6.51% |
| Dividend Growth (YoY) | -51.44% |
| Payout Ratio | -96.81% |
| Earnings Yield | 57.9% |
| FCF Yield | 31.33% |
Analyst Forecast
Currently there are no analyst rating for YIHCF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 7 |